AI is collapsing drug discovery timelines.
Pharma content still drags through weeks of MLR.
Until now.
One Brand Dossier. Five digital co-workers. Purpose built for Pharma brands that can't afford to wait.
Loved by marketing teams
Approved content
arrives too late.
The brand in the queue
One asset stamped โin review,โ cycling back a third time. The window closes. A competitor is already there.
The brand that ships
Live across email, web, video, and point of care the week it matters. Own the conversation. Set the curve.
5 Digital Co-workers. One Platform.
Brief them like your best hires, each pre-trained on the last 12 years of Approved Assets and Award Winning campaigns.

Project Manager
Orchestrates ยท you brief it once

Content Strategist
Plans
Medical Writer
Writes
Creative Producer
Creates
MLR Reviewer
Clears itMarketing Objectives
Core commercial goals mapped from one brief
Audience Segments
Priority audiences planned before production starts
Content Formats
Approved formats produced through five Magic Engines
Time Savings
Less time from brief to review-ready content
Cost Savings
Lower production cost across repeatable assets
MLR Cycle Time
Shorter review cycles with evidence built in
Industryโs First Brand Dossier To Power
30+ Formats. Every Objective. Every Audience.
Five Magic Engines share one Brand Dossier, grounded in medically referenced citations, so every format stays on-brand, on-label, and review-ready.
Magic Aid
Magic Canvas
Magic Mail
Magic Doc
Every model knows medicine.
None of them know your brand.
General AI guesses at your brand. Content IQ starts from your own verified Brand Dossier, so every asset already knows whatโs true.
Technology partners
Built with the best in Frontier AI
OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



Feeds your Veeva and Cortex workflow. Does not replace it.
Content IQ pulls your approved claims and references in, and pushes submission-ready packages out, every claim annotated to its source. It sits upstream of your MLR system, feeding it content that is already clean.
Generates clean, referenced, submission-ready content
Vault
PromoMatsReviews and approves, exactly as it does today
Brief in. Review-ready out.
3 steps from a blank page to an asset your MLR committee can clear in one pass.
Start from your Brand Dossier
Point Content IQ at your own materials, or let us build your Brand Dossier: a single source of truth across the drug, the disease, and the therapeutic area.
- Approved label, PI, and clinical references
- Core claims, mapped to their evidence
- Disease-state and therapeutic-area context
- One source every co-worker generates from

Brand Dossier
Single source of truth
Set the brief
Choose the format, the objective, and the goal, then dial in the details that make it yours.
- Format, objective, and funnel stage
- Audience, tone of voice, and language
- Generate the script, or refine your own
- Apply your brand colors and brand kit

Get a review-ready asset
In minutes: every claim referenced, fair balance in place, ready to enter MLR clean.
- Citations shown by default
- Fair balance and ISI already placed
- Edit any component just by chatting
- Full flexibility on copy, visuals, structure

Tighten the headline
Security and compliance,
engineered in, not bolted on.
Every layer of Content IQ is built to the standards pharma and medtech commercial teams already answer to.
21 CFR 202.1
MLR-ready by design

GDPR
Compliant

HIPAA
Compliant

SOC 2
Type II compliant
TLS 1.2+
Every connection encrypted

AES-256
Encrypted at rest
Full detail on our practices is available on the Security Page.
See it run on your own brand.
Book a 30-minute demo and watch a brief become a review-ready asset before the call ends. Or start free and make one yourself.


